400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / Adenosine Deaminase / 克拉利宾
CAS No.: 4291-63-8
Synonyms: 2-Chloro-2′-deoxyadenosine;CldAdo;2CdA
Cladribine is an adenosine deaminase inhibitor used to treat hairy cell leukemia and multiple sclerosis. For U266, RPMI8226, and MM1.S cells, its IC50 are approximately 2.43 μM, 0.75 μM, and 0.18 μM, respectively.
生物活性
靶点 | Adenosine Deaminase IC50:0.18μM(in MM1.S cells) |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02096055 | Leukemia | Phase 2 | Active, not recruiting | April 2026 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00691652 | Lymphoma | Phase 1 Phase 2 | Terminated | - | United States, Oregon ... more >> Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Collapse << |
NCT00117598 | Lymphoma | Phase 3 | Completed | - | - |
实验方案
技术信息
CAS号 | 4291-63-8 | 储存条件 |
|
|||||||||||
分子式 | C10H12ClN5O3 | 运输 | 蓝冰 | |||||||||||
分子量 | 285.69 | 别名 | 2-Chloro-2′-deoxyadenosine;CldAdo;2CdA;2-Chlorodeoxyadenosine;Jk 6251;NSC 105014;RWJ 26251;Cladribina. US brand name: Leustatin. Foreign brand names: Leustat;Leustatine. Abbreviations: 2CDA;2CdA. Code name: RWJ26251. Chemical structure names: * 2chloro2deoxyadenosine;* 2chlorodeoxyadenosine;克拉屈滨 | |||||||||||
溶解度 |
|
动物实验配方 |
|
Cell Lines | Concentration | Assay Type | Time | Activity Description | Data Sources |
---|
BT549 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human BT549 cells after 3 days by MTT assay, IC50=0.123 μM | 21711054 |
CCRF-CEM cell lines | - | Cytotoxicity assay | - | Compound was tested for cytotoxicity against CCRF-CEM cell lines, IC50=0.003 μM | 1732556 |
CCRF-CEM cells | - | Cytotoxicity assay | 72 h | Cytotoxicity against human CCRF-CEM cells after 72 hrs by MTT assay, IC50=0.0005 μM | 21840722 |
CEM-DNR-bulk cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human CEM-DNR-bulk cells after 3 days by MTT assay, IC50=0.352 μM | 21711054 |
HEp-2 cell lines | - | Cytotoxicity assay | - | Compound was tested for cytotoxicity against HEp-2 cell lines, IC50=0.03 μM | 1732556 |
human BV173 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human BV173 cells after 3 days by MTT assay, IC50=0.0008 μM | 21711054 |
human HCT116 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human HCT116 cells after 3 days by MTT assay, IC50=9.43 μM | 21711054 |
human HCT116 cells | - | Cytotoxicity assay | 72 h | Cytotoxicity against human HCT116 cells after 72 hrs by SRB assay, IC50=0.3 μM | 25462277 |
human HPAC cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human HPAC cells after 3 days by MTT assay, IC50=9.32 μM | 21711054 |
human HT-29 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human HT-29 cells after 3 days by MTT assay, IC50=9.44 μM | 21711054 |
human HuH7 cells | - | Cytotoxicity assay | 72 h | Cytotoxicity against human HuH7 cells after 72 hrs by SRB assay, IC50=1.8 μM | 25462277 |
human K562 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human K562 cells after 3 days by MTT assay, IC50=7.69 μM | 21711054 |
human K562 cells | - | Proliferation assay | 48 h | Antiproliferative activity against human K562 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=10 μM | 25960323 |
human KG1 cells | - | Proliferation assay | 48 h | Antiproliferative activity against human KG1 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=0.2 μM | 25960323 |
human MCF7 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human MCF7 cells after 3 days by MTT assay, IC50=2.35 μM | 21711054 |
human MCF7 cells | - | Proliferation assay | 48 h | Antiproliferative activity against human MCF7 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=45 μM | 25960323 |
human MOLT3 cells | - | Proliferation assay | 48 h | Antiproliferative activity against human MOLT3 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=2.3 μM | 25960323 |
human PC3 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human PC3 cells after 3 days by MTT assay, IC50=8.28 μM | 21711054 |
human Raji cells | - | Cytotoxicity assay | 72 h | Cytotoxicity against human Raji cells after 72 hrs by MTT assay, IC50=0.009 μM | 21840722 |
human RPMI8226 cells | - | Proliferation assay | 48 h | Antiproliferative activity against human RPMI8226 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=6 μM | 25960323 |
human SKHEP1 cells | - | Proliferation assay | 48 h | Antiproliferative activity against human SKHEP1 cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=4 μM | 25960323 |
human SK-UT-1B cells | - | Proliferation assay | 48 h | Antiproliferative activity against human SK-UT-1B cells assessed as cell growth inhibition after 48 hrs by MTT assay, IC50=1 μM | 25960323 |
human T47D cells | - | Cytotoxicity assay | 72 h | Cytotoxicity against human T47D cells after 72 hrs by SRB assay, IC50=0.7 μM | 25462277 |
L1210 cell lines | - | Cytotoxicity assay | - | Compound was tested for cytotoxicity against L1210 cell lines, IC50=0.07 Μm | 1732556 |
L1210 cell lines | - | Function assay | - | In vitro inhibitory effect was tested for cytostatic activity on the growth of murine leukemic L1210 cell lines, ID50=0.03 μM | 2995666 |
MES-SA cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against human MES-SA cells after 3 days by MTT assay, IC50=0.165 μM | 21711054 |
mouse CT26 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against mouse CT26 cells after 3 days by MTT assay, IC50=0.131 μM | 21711054 |
mouse EL4 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against mouse EL4 cells after 3 days by MTT assay, IC50=0.848 μM | 21711054 |
mouse L1210 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against mouse L1210 cells after 3 days by MTT assay, IC50=0.393 μM | 21711054 |
mouse P388D1 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against mouse P388D1 cells after 3 days by MTT assay, IC50=0.285 μM | 21711054 |
P388 leukemic cell lines | - | Function assay | - | In vitro inhibitory effect was tested for cytostatic activity on the growth of lymphoid neoplasm P388 leukemic cell lines, ID50=0.03 μM | 2995666 |
rat C6 cells | - | Cytotoxicity assay | 3 days | Cytotoxicity against rat C6 cells after 3 days by MTT assay, IC50=9.07 μM | 21711054 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02096055 | Leukemia | Phase 2 | Active, not recruiting | April 2026 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00691652 | Lymphoma | Phase 1 Phase 2 | Terminated | - | United States, Oregon ... more >> Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Collapse << |
NCT00117598 | Lymphoma | Phase 3 | Completed | - | - |
NCT01364363 | Severe Aplastic Anemia ... more >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Myeloproliferative Syndromes Chronic Myelogenous Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Large Granulocytic Leukemia Collapse << | Not Applicable | Recruiting | January 2023 | United States, California ... more >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Carol Burian 858-554-2845 Burian.Carol@scrippshealth.org Principal Investigator: Jeffrey W. Andrey, MD Collapse << |
NCT00117598 | - | - | Completed | - | - |
NCT00199017 | Lymphoma, Lymphoblastic | Phase 4 | Completed | - | Germany ... more >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Collapse << |
NCT00198991 | Adult Acute Lymphocytic Leukem... more >>ia Collapse << | Phase 4 | Unknown | - | Germany ... more >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD ++49(0)69 6301 5194 hoelzer@em.uni-frankfurt.de Contact: Nicola Goekbuget, MD ++49(0)69 6301 6365 goekbuget@em.uni-frankfurt.de Principal Investigator: Dieter Hoelzer, MD,PhD Sub-Investigator: Nicola Goekbuget, MD Collapse << |
NCT02551718 | Acute Leukemia of Ambiguous Li... more >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Collapse << | Not Applicable | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker 206-616-1589 pbecker@u.washington.edu Principal Investigator: Pamela S. Becker Collapse << |
NCT00691652 | - | - | Terminated | - | - |
NCT00004904 | Chronic Myeloproliferative Dis... more >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Small Intestine Cancer Collapse << | Phase 1 | Completed | - | United States, Illinois ... more >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Collapse << |
NCT02676856 | Acute Myeloid Leukemia | Not Applicable | Unknown | August 2018 | China, Guangdong ... more >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Fen Huang +86-020-62787883 13826204917@163.com Collapse << |
NCT02665065 | Acute Myeloid Leukemia ... more >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Collapse << | Phase 3 | Recruiting | June 2020 | United States, Arizona ... more >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Collapse << |
NCT00001567 | Hairy Cell Leukemia | Phase 2 | Completed | - | United States, Maryland ... more >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Collapse << |
NCT02788201 | Urothelial Carcinoma ... more >> Bladder Cancer Urinary Bladder Neoplasms Collapse << | Phase 2 | Recruiting | July 1, 2020 | United States, Maryland ... more >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 Collapse << |
NCT00708721 | Cancer Chroni... more >>c Myelomonocytic Leukemia Collapse << | Phase 1 Phase 2 | Terminated(Data analysis revea... more >>led sufficient data for safety and efficacy) Collapse << | - | United States, Utah ... more >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Collapse << |
NCT00708721 | - | - | Terminated(Data analysis revea... more >>led sufficient data for safety and efficacy) Collapse << | - | - |
NCT02425904 | Langerhans Cell Histiocytosis | Phase 2 | Recruiting | September 2022 | United States, Arizona ... more >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Michael Henry, MD 602-933-0920 MHenry@phoenixchildrens.com United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD 501-364-1494 StineKimoC@uams.edu United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD 323-361-5639 rjubran@chla.usc.edu University of California San Francisco Medical Center Recruiting San Francisco, California, United States, 94143 Contact: Michelle Hermiston, MD 415-476-3831 HermistonM@peds.ucsf.edu United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephen Ladisch, MD sladisch@childrensnational.org United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: David Ebb, MD 617-726-2737 DEBB@mgh.harvard.edu Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD 617-632-5186 Barbara_Degar@dfci.harvard.edu Principal Investigator: Barbara Degar, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD 617-632-5186 barbara_degar@dfci.harvard.edu Principal Investigator: Barbara Degar, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Eric Jacobsen, MD 617-632-6633 EdJacobsen@partners.org United States, New York Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Birte Wistinghausen, MD 212-241-7022 Birte.wistinghausen@mssm.edu United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Ashish Kumar, MD 513-803-1631 Ashish.Kumar@cchmc.org United States, Pennsylvania The Children's Hospital of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michael Hogarty, MD 215-590-2821 hogartym@email.chop.edu United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD patrick.campbell@stjude.org Principal Investigator: Patrick Campbell, MD United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carl Allen, MD 832-822-4890 ceallen@txch.org Collapse << |
NCT01534702 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Unknown | September 2015 | Germany ... more >> Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Andrea Kuendgen, MD andrea.kuendgen@med.uni-duesseldorf.de Principal Investigator: Andrea Kuendgen, MD Klinikum Essen-Werden Recruiting Essen, Germany, 45239 Contact: Mohammad Wattad, MD m.wattad@kliniken-essen-sued.de Principal Investigator: Mohammad Wattad, MD Universitätsklinikum Freiburg Recruiting Freiburg, Germany, D-79106 Contact: Michael Luebbert, MD luebbert@mm11.ukl.uni-freiburg.de Principal Investigator: Michael Luebbert, MD Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Walter Fiedler, MD fiedler@uke.uni-hamburg.de Principal Investigator: Walter Fiedler, MD Hannover Medical School Recruiting Hannover, Germany, D-30625 Contact: Juergen Krauter, MD +49-511-532-3720 Krauter.Juergen@MH-Hannover.de Principal Investigator: Juergen Krauter, MD Klinikum Rechts der Isar Not yet recruiting Muenchen, Germany, 81675 Contact: Justus Duyster justus.duyster@lrz.tum.de Principal Investigator: Justus Duyster, MD Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Richard Schlenk, MD Richard.Schlenk@uniklinik-ulm.de Principal Investigator: Richard Schlenk, MD Collapse << |
NCT03150004 | Acute Myeloid Leukemia | Phase 2 | Recruiting | June 1, 2020 | United States, Wisconsin ... more >> Froedtert & the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Medical College of Wisconsin Clinical Cancer Center 414-805-8900 cccto@mcw.edu Collapse << |
NCT00028418 | Hematologic Neoplasms ... more >> Lymphoproliferative Disorders Leukemia Leukemia, Lymphocytic, Chronic Collapse << | Phase 1 | Completed | - | United States, Texas ... more >> University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT02883946 | - | - | Completed | - | France ... more >> Chu de Reims Reims, France, 51092 Collapse << |
NCT01334996 | - | - | Recruiting | October 2020 | United States, Minnesota ... more >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55901 Contact: Joseph H Butterfield, MD 507-284-3783 butterfield.joseph@mayo.edu Collapse << |
NCT02205762 | Langerhans Cell Histiocytosis | Phase 2 Phase 3 | Recruiting | July 2023 | United States, Arizona ... more >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85006 Contact: Michael Henry, MD mhenry@phoenixchildrens.com Principal Investigator: Michael Henry, MD United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kimo Stine, MD stinekimoc@uams.edu Principal Investigator: Kimo Stine, MD United States, California Children's Hospital of Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Rima Jubran, MD rjubran@chla.usc.edu Principal Investigator: Rima Jubran, MD Valley Children's Healthcare Not yet recruiting Madera, California, United States, 93636 Contact: David Samuel, MD DSamuel@valleychildrens.org Contact: Faisal Razzaqi, MD FRazzaqi@valleychildrens.org Principal Investigator: David Samuel, MD United States, Connecticut Connecticut Children's Medical Center Not yet recruiting Hartford, Connecticut, United States, 06106 Contact: Andrea Orsey, MD aorsey@connecticutchildrens.org Principal Investigator: Andrea Orsey, MD United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Stephan Ladisch, MD sladisch@childrensnational.org Contact: Jay Greenberg, MD jagreenb@childrensnational.org United States, Maryland Johns Hopkins University Not yet recruiting Baltimore, Maryland, United States, 21287 Contact: Elias Zambidis, MD EZambid1@jhmi.edu Contact: Christine Pratilas, MD Cpratil1@jhmi.edu United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Mary Huang, MD 617-726-2737 mshuang@partners.org Principal Investigator: Mary Huang, MD Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Barbara Degar, MD 617-632-6801 bdegar@partners.org Principal Investigator: Barbara Degar, MD United States, Minnesota Children's Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Michael Richards, MD Michael.richards@childrensmn.org Contact: Nathan Gossai, MD nathan.gossai@childrensmn.org United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Steven Diamond, MD Steven.Diamond@hackensackmeridian.org Contact: Burton Appel, MD Burton.appel@hackensackmeridian.org United States, New York Cohen Children's Medical Center Recruiting New Hyde Park, New York, United States, 11040 Contact: Carolyn Fein Levy, MD clevy4@northwell.edu Contact: Jeffery Lipton, MD jlipton@northwell.edu Columbia University / Herbert Irving Cancer Center Recruiting New York, New York, United States, 10032 Contact: Maria Luis Sulis, MD mls95@cumc.columbia.edu Contact: Julia Glade Bender, MD jg589@cumc.columbia.edu Staten Island University Hospital Recruiting Staten Island, New York, United States, 10305 Contact: Sarah Vaiselbuh, MD 718-226-6435 svaiselbuh@nshs.edu Principal Investigator: Sarah Vaiselbuh`, MD SUNY Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Melanie Comito, MD comitom@upstate.edu Contact: Andrea Dvorak, MD dvoraka@upstate.edu United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Michael Jordan, MD 513-636-1773 Michael.jordan@cchmc.org Contact: Ashish Kumar, MD 513-803-1631 ashish.kumar@cchmc.org United States, South Carolina Medical Universtiy of South Carolina/Hollings Cancer Center Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Jacqueline Kraveka, DO 843-792-2957 kravekjm@musc.edu Principal Investigator: Jacqueline Kraveka, DO United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Patrick Campbell, MD patrick.campbell@stjude.org Principal Investigator: Patrick Campbell, MD United States, Washington Providence Sacred Heart Children's Hospital Recruiting Spokane, Washington, United States, 99204 Contact: Stefanos Intzes, MD stefanos.intzes@providence.org Contact: Judy Felgenhauer, MD judy.felgenhauer@providence.org Collapse << |
NCT02272478 | Acute Myeloid Leukaemia ... more >> Myelodysplastic Syndrome Collapse << | Phase 2 Phase 3 | Recruiting | October 2020 | United Kingdom ... more >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD Collapse << |
NCT00002805 | Leukemia | Phase 2 | Completed | - | - |
NCT02072811 | Acute Myeloid Leukemia | Phase 3 | Unknown | February 2018 | Poland ... more >> Copernicus Memorial Hospital Recruiting Lodz, Poland, 93-510 Principal Investigator: Agnieszka Wierzbowska, Dr hab. n. med. Collapse << |
NCT03257241 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 31, 2020 | Poland ... more >> Medical University of Bialystok Clinical Hospital Recruiting Białystok, Poland, 15-276 Contact: Jarosław Piszcz, Dr Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena Wątek, Dr Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Małgorzata Raźny, Dr Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Hołojda Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof. Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Kaźmierczak, Dr Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting Łódź, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof. +48426895191 agawierzbowska@wp.pl Collapse << |
NCT00136084 | Leukemia, Myelocytic, Acute | Phase 3 | Completed | - | United States, California ... more >> Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Collapse << |
NCT00136084 | - | - | Completed | - | - |
NCT02756572 | Blasts 10 Percent or More of B... more >>one Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Grade Malignant Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Collapse << | Not Applicable | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mary-Elizabeth M. Percival 206-606-1320 mperciva@seattlecca.org Principal Investigator: Mary-Elizabeth M. Percival Collapse << |
NCT00955916 | Leukemia | Phase 2 | Completed | - | United States, Florida ... more >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Collapse << |
NCT00111345 | Myeloid Leukemia | Phase 2 Phase 3 | Unknown | March 2017 | Germany ... more >> University Children's Hospital Muenster, Department of Paediatric Haematology and Oncology Muenster, North Rhine-Westphalia, Germany, D-48129 Collapse << |
NCT02416908 | Acute Myeloid Leukemia | Phase 1 Phase 2 | Active, not recruiting | June 30, 2019 | United States, Missouri ... more >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Collapse << |
NCT00955916 | - | - | Completed | - | - |
NCT00594555 | Chronic Myeloid Leukemia, Blas... more >>t Crisis Acute Myeloid Leukemia Collapse << | Phase 2 | Withdrawn(Principal Investigat... more >>or resigned position with the University of Cincinnati, closing study at this site will reopen study in new position) Collapse << | November 2008 | United States, Ohio ... more >> University of Cincinnati Cincinnati, Ohio, United States, 45267 Collapse << |
NCT00002833 | Graft Versus Host Disease ... more >> Leukemia Myelodysplastic Syndromes Collapse << | Phase 2 | Completed | - | United States, Texas ... more >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT03441048 | Acute Myeloid Leukemia | Phase 1 | Recruiting | April 1, 2020 | United States, Wisconsin ... more >> Froedtert Hospital and the Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Cancer Center Clinical Trials Office 866-680-0505 ext 8900 cccto@mcw.edu Principal Investigator: Sameem Abedin, MD Collapse << |
NCT03589729 | Acute Myeloid Leukemia ... more >> Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blasts 10 Percent or More of Bone Marrow Nucleated Cells High Risk Myelodysplastic Syndrome Myeloid Sarcoma Myeloproliferative Neoplasm Philadelphia Chromosome Positive Collapse << | Phase 2 | Recruiting | December 31, 2020 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Maro Ohanian 713-792-2631 Principal Investigator: Maro Ohanian Collapse << |
NCT00199030 | Adult Acute Lymphocytic Leukem... more >>ia T-Cell Lymphoma, Lymphoblastic Collapse << | Phase 2 | Completed | - | Germany ... more >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Collapse << |
NCT00074048 | Leukemia | Phase 2 | Completed | - | United States, Maryland ... more >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Collapse << |
NCT01295593 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Unknown | April 2013 | Belgium ... more >> Clinique Sud Luxembourg Recruiting Arlon, Belgium, 6700 Contact: Pascal Pierre, MD Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Dominique Bron, MD, PhD ULB Erasme Recruiting Brussels, Belgium, 1070 Contact: Alain Kentos, MD Cliniques universitaires Saint Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Eric Van Den Neste, MD, PhD Grand Hôpital de Charleori - Site notre Dame Recruiting Charleroi, Belgium, 6000 Contact: Marc André, MD Clinique Notre-Dame de Grâce Recruiting Gosselies, Belgium, 6041 Contact: Marie Maerevoet, MD Hôpital de Jolimont Recruiting Haine-St-Paul, Belgium, 7100 Contact: Valérie Delrieu, MD CHU ULg Recruiting Liège, Belgium, 4000 Contact: Bernard De Prijck, MD Clinique Saint Pierre Recruiting Ottignies, Belgium, 1340 Contact: Thierry Connerotte, MD, PhD Heilig-Hartziekenhuis Recruiting Roeselaere, Belgium, 8800 Contact: Hilde Demuynck, MD Cliniques de Mont Godinne Recruiting Yvoir, Belgium, 5530 Contact: Christian Chatelain, MD, PhD Collapse << |
NCT03369665 | Multiple Sclerosis | Phase 4 | Recruiting | November 25, 2021 | Austria ... more >> Kepler Universitätsklinikum Recruiting Linz, Austria, 4021 Principal Investigator: Michael Guger Belgium Hôpital Erasme Recruiting Brussels, Belgium, 1070 Principal Investigator: Gaetano Perrotta Cliniques Univ. St.-Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Vincent Van Pesch UZ Antwerpen Recruiting Edegem, Belgium, 2650 Principal Investigator: Barbara Willekens Jessa Ziekenhuis Recruiting Hasselt, Belgium, 3500 Principal Investigator: Nina De Klippel Clinique Saint Pierre Recruiting Ottignies, Belgium, 1340 Principal Investigator: Philippe Jacquerye Czechia FN u sv. Anny Brno Recruiting Brno, Czechia, 65691 Principal Investigator: Michel Dufek FN Hradec Kralove Recruiting Chocen, Czechia, 56501 Principal Investigator: Martin Valis Nemocnice Jihlava, p.o. Recruiting Jihlava, Czechia, 586 33 Principal Investigator: Radek Ampapa Denmark Aalborg Hospital Recruiting Aalborg, Denmark, 9100 Principal Investigator: Claudia Pfleger Matthias Kant Recruiting Sønderborg, Denmark, 6400 Principal Investigator: Matthias Kant Finland Helsinki University Central Hospital Recruiting Helsinki, Finland, 290 Principal Investigator: Annuka Uusitalo Terveystalo Mikkeli Recruiting Mikkeli, Finland, 50100 Principal Investigator: Sakari Simula Hungary University of Debrecen Recruiting Debrecen, Hungary, 4032 Principal Investigator: Tünde Csepany VALEOMED Kft Recruiting Esztergom, Hungary, 2500 Principal Investigator: Maria Satori Lithuania Hospital of Lithuanian University of Health Sciences Kaunas Recruiting Kaunas, Lithuania, 50161 Principal Investigator: Antanas Vaitkus Klaipedos Ligonine Recruiting Kaunas, Lithuania, 50161 Principal Investigator: Lina Malciene Vilnius University Hospital Santariskiu Clinics Recruiting Vilnius, Lithuania, 8661 Principal Investigator: Rasa Kizlaitiene Netherlands Zuyderland Recruiting Sittard-Geleen, Netherlands, 6131 BG Principal Investigator: Raymond Hupperts Poland M.A. - LEK A.M.Maciejowscy SC. Recruiting Katowice, Poland, 40-571 Principal Investigator: Maciej Maciejowski Centrum Medyczne Medyk Recruiting Lublin, Poland, 20-954 Principal Investigator: Halina Bartosik Psujek Indywidualna Praktyka Lekarska Prof. Konrad Rejdak Recruiting Lublin, Poland, 20-954 Principal Investigator: Konrad Rejdak Centrum Neurologii K. Selmaj Recruiting Łódź, Poland, 90-153 Principal Investigator: Krzysztof Selmaj Collapse << |
NCT00019071 | Brain and Central Nervous Syst... more >>em Tumors Collapse << | Phase 1 | Completed | - | United States, Maryland ... more >> Radiation Oncology Branch Bethesda, Maryland, United States, 20892 Collapse << |
NCT02323022 | Acute Myeloid Leukemia | Phase 3 | Recruiting | December 2020 | China, Jiangsu ... more >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Jia Chen, M.D. +86 512 6778 1856 chenjiasuzhou@gmail.com Collapse << |
NCT00003757 | Leukemia | Phase 2 | Completed | - | Switzerland ... more >> Klinik Hirslanden Zurich, Switzerland, CH-8008 Collapse << |
NCT03364036 | Multiple Sclerosis | Phase 4 | Recruiting | December 31, 2021 | Germany ... more >> Merck KGaA Communication Center Recruiting Darmstadt, Germany, 64293 Collapse << |
NCT01513603 | Acute Lymphoblastic Leukemia ... more >> Lymphoblastic Lymphoma Burkitts Leukemia/Lymphoma Chronic Myelogenous Leukemia Collapse << | Phase 2 | Unknown | January 2014 | United States, New York ... more >> Westchester Medical Center/New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Karen Seiter, MD 914-493-7514 karen_seiter@nymc.edu Principal Investigator: Karen Seiter, MD Sub-Investigator: Delong Liu, MD, PhD Sub-Investigator: Claudio Sandoval, MD Collapse << |
NCT03384225 | High Risk Acute Myeloid Leukem... more >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Collapse << | Phase 3 | Recruiting | July 31, 2020 | China, Shanghai ... more >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D. 86-21-63069298 sfph_edu2@163.com Contact: Yanhong Zhu 86-21-63240090 ext 6213 sfph_edu2@shumu.edu.cn Sub-Investigator: Jieling Jiang, M.D. Principal Investigator: Xiaoxia Hu, M.D. Principal Investigator: Qiang Liu, M.D. Principal Investigator: Yajing Xu, M.D. Principal Investigator: Ting Yang, M.D. Principal Investigator: Huangfang Wang, M.D. Sub-Investigator: Yang Cao, M.D. Collapse << |
NCT03602131 | Hodgkin Lymphoma ... more >> Non-hodgkin Lymphoma Collapse << | Phase 2 | Not yet recruiting | March 30, 2021 | - |
NCT00258271 | Leukemia | Phase 1 | Completed | - | United States, New York ... more >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Collapse << |
NCT03384212 | High Risk Acute Myeloid Leukem... more >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Collapse << | Phase 3 | Recruiting | July 31, 2020 | China, Shanghai ... more >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D. 86-21-63069298 sfph_edu2@163.com Contact: Yanhong Zhu 86-21-63240090 ext 6213 sfph_edu2@shumu.edu.cn Sub-Investigator: Jieling Jiang, M.D. Principal Investigator: Xiaoxia Hu, M.D. Principal Investigator: Qiang Liu, M.D. Principal Investigator: Yajing Xu, M.D. Principal Investigator: Ting Yang, M.D. Principal Investigator: Huangfang Wang, M.D. Sub-Investigator: Yang Cao, M.D. Collapse << |
NCT01272817 | Aplastic Anemia ... more >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Myelodysplastic Syndrome Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Mantle Cell Lymphoma Multiple Myeloma Waldenstrom Macroglobulinemia Breast Cancer Renal Cell Carcinoma Melanoma Sarcoma Ovarian Cancer Thymoma Collapse << | Not Applicable | Unknown | - | United States, California ... more >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Cynthia Nelson, R.N. 858-554-2814 nelson.cynthia@scrippshealth.org Contact: Laurie Cobarrubia, R.N. 858-554-2853 cobarrubia.laurie@scrippshealth.org Principal Investigator: Jeffrey W. Andrey, M.D. Sub-Investigator: James R. Mason, M.D. Sub-Investigator: William E. Miller, M.D. Collapse << |
NCT00072007 | Leukemia | Phase 2 | Completed | - | Switzerland ... more >> Kantonspital Aarau Aarau, Switzerland, 5001 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitaeler Chur AG Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital, Luzerne Luzerne, Switzerland, CH-6000 Hopital des Cadolles, Neuchatel Neuchatel, Switzerland, 2000 Praxis Dr. Beretta Rheinfelden, Switzerland, 4310 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Onkozentrum Zurich, Switzerland, 8038 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Collapse << |
NCT03012672 | Acute Leukemia of Ambiguous Li... more >>neage Acute Myeloid Leukemia Myeloid Neoplasm Collapse << | Phase 2 | Recruiting | July 15, 2020 | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern 206-667-6233 Principal Investigator: Anna Halpern Collapse << |
NCT00003178 | Leukemia | Phase 2 | Completed | - | - |
NCT03151876 | Lymphoma | Phase 2 | Recruiting | December 2021 | China, Beijing ... more >> Beijing cancer hospital Not yet recruiting Beijing, Beijing, China, 100142 Contact: Yan Xie, MD Peking university third hospital Not yet recruiting Beijing, Beijing, China, 100191 Contact: Xiaoyan Ke, MD China, Chongqing The first affiliated hospital of Chongqing medical university Not yet recruiting Chongqing, Chongqing, China, 400016 Contact: Lin Liu, MD Southwest Hospital Recruiting Chongqing, Chongqing, China, 400038 Contact: Dabing Qin, MD China, Gansu General Hospital of Lanzhou military command Not yet recruiting Lanzhou, Gansu, China, 730070 Contact: Hai Bai, MD China, Henan Henan cancer hospital Not yet recruiting Zhengzhou, Henan, China, 450008 Contact: Jian Zhou, MD The first affiliated hospital of Zhengzhou university Not yet recruiting Zhengzhou, Henan, China, 450052 Contact: Xinhua Wang, MD China, Hubei Tongji Hospital Not yet recruiting Wuhan, Hubei, China, 430030 Contact: Yang Cao, MD China, Jiangsu Jiangsu province hospital Not yet recruiting Nanjing, Jiangsu, China, 210029 Contact: Wei Xu, MD China, Shanghai Rui jin hospital Shanghai jiao tong University Not yet recruiting Shanghai, Shanghai, China, 200025 Contact: Jiong Hu, MD Tong Ren Hospital Not yet recruiting Shanghai, Shanghai, China Contact: Ligen L i u, MD China, Shanxi Shan Xi Da Yi Hospital Not yet recruiting Taiyuan, Shanxi, China, 030032 Contact: Rong Gong, MD Tangdu Hospital Not yet recruiting Xi'an, Shanxi, China, 710038 Contact: Qiang Liu, MD China, Sichuan West China Hospital of Sichuan University Recruiting Chengdu, Sichuan, China, 610044 Contact: Jie Ji, MD 86-28-85422370 jieji@scu.edu.cn Affiliated Hospital of Southwest Medical University Recruiting Nanchong, Sichuan, China, 646000 Contact: Xiaoming Li, MD China, Tianjing Blood diseases hospital, Chinese academy of medica Not yet recruiting Tianjin, Tianjing, China, 300020 Contact: Lvgui Qiu, MD China, Xinjiang The first affiliated hospital of Xinjiang medical Universtiy Not yet recruiting Ürümqi, Xinjiang, China, 830054 Contact: Ming Jiang, MD China, Yunnan Kunming General Hospital of Chengdu Military Area Not yet recruiting Kunming, Yunnan, China, 650032 Contact: Sanbin Wang, MD Collapse << |
NCT00641537 | Relapsing-Remitting Multiple S... more >>clerosis Collapse << | Phase 3 | Completed | - | - |
NCT02910752 | Leukemia | Phase 1 Phase 2 | Recruiting | September 2020 | China ... more >> Rui Jin Hospital, Department of Hematology Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D., 86-21-64370045 hujiong@medmail.com.cn Contact: Ling Wang, M.D., 86-21-64370045 cclingjar@163.com Collapse << |
NCT03585686 | Langerhans Cell Histiocytosis | Phase 2 | Recruiting | December 2020 | Russian Federation ... more >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117997 Contact: Zhanna Shekhovtsova, MD 4956647078 ext 7538 zhanna.shekhovtsova@fccho-moscow.ru Contact: Eugene Pashanov, PhD +79262205578 e.pashanov@gmail.com Sub-Investigator: Dmitry Evseev, MD Principal Investigator: Michael Maschan, PhD Collapse << |
NCT00004762 | Cholangitis, Sclerosing | Phase 2 | Completed | - | - |
NCT00641537 | - | - | Completed | - | - |
NCT00718549 | Lymphocytic Leukemia, Chronic | Phase 3 | Completed | - | Belarus ... more >> City Clinical Hospital #9 Minsk, Belarus, 220116 Poland Medical University, Independent Public Clinical Hospital; Dept. of Hematology, SPSK Bialystok, Poland, 15-276 Szpital Uniwersytecki W Krakowie; Klinika Hematologii Krakow, Poland, 31-501 Medical University School; Dept. of Haematology Lodz, Poland, 93-510 Istytut Hematologii i Transfuzjologii; Hematologia Warszawa, Poland, 02 776 Medical Uni of Wroclaw; Hematology Wroclaw, Poland, 50-367 Collapse << |
NCT00718549 | - | - | Completed | - | - |
NCT02728050 | Acute Biphenotypic Leukemia ... more >> Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome High Risk Myelodysplastic Syndrome Myelodysplastic Syndrome Myeloproliferative Neoplasm Collapse << | Phase 1 Phase 2 | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Anna Halpern 206-314-5944 halpern2@uw.edu Principal Investigator: Anna Halpern Collapse << |
NCT00003174 | Leukemia | Phase 1 | Completed | - | United States, Michigan ... more >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48202-1379 Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States, 48236 Collapse << |
NCT00003746 | Leukemia | Phase 3 | Completed | - | Switzerland ... more >> Inselspital Bern Bern, Switzerland, CH-3010 Collapse << |
NCT00656812 | Lymphoma of Mucosa-Associated ... more >>Lymphoid Tissue Collapse << | Phase 2 | Completed | - | Austria ... more >> Universitätsklinikum Graz Graz, Austria, A-8036 Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria, A-6020 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 AKH Wien / Universitaetsklinik fuer Innere Medizin I Vienna, Austria, A-1090 Collapse << |
NCT01161550 | Leukemia, Myeloid, Acute | Phase 1 | Completed | - | United States, Missouri ... more >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Collapse << |
NCT00436826 | - | - | Completed | - | - |
NCT00764517 | Recurrent B-Cell Non-Hodgkin L... more >>ymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Indolent Adult Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Collapse << | Phase 2 | Completed | - | United States, Oregon ... more >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Collapse << |
NCT00667329 | Lymphoma | Phase 1 | Active, not recruiting | July 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00787969 | Lymphoma | Phase 1 | Completed | - | - |
NCT03531918 | Acute Myeloid Leukemia ... more >> High-Grade Myeloid Neoplasm Collapse << | Phase 1 Phase 2 | Recruiting | July 1, 2025 | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Roland Walters 206-667-3599 rwalter@fredhutch.org Principal Investigator: Roland Walters Collapse << |
NCT00764517 | - | - | Completed | - | - |
NCT02921061 | Mixed Phenotype Acute Leukemia... more >> Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent High Risk Myelodysplastic Syndrome Refractory Acute Myeloid Leukemia Refractory High Risk Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Collapse << | Phase 1 Phase 2 | Recruiting | - | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Sarah A. Buckley 206-416-5066 sbuckley@fredhutch.org Principal Investigator: Sarah A. Buckley Collapse << |
NCT00483067 | Leukemia | Phase 2 | Completed | - | United States, Texas ... more >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Collapse << |
NCT00053027 | Lymphoma | Phase 2 | Completed | - | - |
NCT00213135 | Multiple Sclerosis, Relapsing-... more >>Remitting Collapse << | Phase 3 | Completed | - | - |
NCT00436826 | Multiple Sclerosis | Phase 2 | Completed | - | - |
NCT00213135 | - | - | Completed | - | - |
NCT00725985 | Multiple Sclerosis | Phase 3 | Completed | - | - |
NCT03586609 | Acute Myeloid Leukemia | Phase 2 | Recruiting | January 3, 2020 | United States, Texas ... more >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Tapan M. Kadia 713-563-3534 Principal Investigator: Tapan M. Kadia Collapse << |
NCT00725985 | - | - | Completed | - | - |
NCT02115295 | Leukemia | Phase 2 | Recruiting | May 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT02044796 | Acute Biphenotypic Leukemia ... more >> de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Collapse << | Phase 1 Phase 2 | Active, not recruiting | August 1, 2022 | United States, Washington ... more >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Collapse << |
NCT00002879 | Lymphoma | Phase 2 | Completed | - | United States, Arizona ... more >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Collapse << |
NCT00126321 | Leukemia, Myelocytic, Acute | Phase 2 | Unknown | March 2011 | Germany ... more >> Medical Clinic & Policlinic III, University Bonn Recruiting Bonn, Germany, 53105 Contact: Marie von Lilienfeld-Toal, MD +49-228-287-22263 m.lilienfeld.toal@uni-bonn.de Principal Investigator: Marie von Lilienfeld-Toal, MD Collapse << |
NCT01439750 | Mantle Cell Lymphoma | Phase 1 | Active, not recruiting | August 2020 | United States, Pennsylvania ... more >> Penn State Cancer Institute Hershey, Pennsylvania, United States, 17033 Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Collapse << |
NCT02250937 | Acute Myeloid Leukemia ... more >> Myelodysplastic Syndrome Collapse << | Phase 2 | Recruiting | October 2020 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT00412594 | Leukemia | Phase 2 | Recruiting | June 2019 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT00980395 | Lymphoma Mant... more >>le Cell Lymphoma Indolent Lymphoma SLL Collapse << | Phase 2 | Active, not recruiting | December 31, 2021 | United States, Arizona ... more >> The University of Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 Collapse << |
NCT01446900 | Chronic Lymphocytic Leukaemia ... more >> Small Lymphocytic Lymphoma Collapse << | Phase 2 | Terminated(low rate in patient... more >> accrual) Collapse << | - | Italy ... more >> European Institute of Oncology Milan, Italy Collapse << |
NCT01473797 | Langerhans Cell Histiocytosis ... more >>of Lung Collapse << | Phase 2 | Active, not recruiting | April 2022 | France ... more >> Saint Louis hospital Paris, France, 75010 Collapse << |
NCT00923013 | Hairy Cell Leukemia | Phase 2 | Recruiting | December 31, 2018 | United States, Maryland ... more >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office (888) NCI-1937 Collapse << |
NCT01515527 | Leukemia | Phase 2 | Recruiting | February 2021 | United States, Texas ... more >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Collapse << |
NCT01602939 | Systemic Mastocytosis | Phase 2 Phase 3 | Unknown | June 2017 | Spain ... more >> Instituto de Estudios de Mastocitosis de Castilla La Mancha; Hospital Virgen del Valle Recruiting Toledo, Spain, 45071 Contact: Luis Escribano, MD, PhD +34925269335 lescribanom@sescam.jccm.es Contact: Iván Alvarez-Twose, MD +34925269336 ivana@sescam.jccm.es Principal Investigator: Luis Escribano, MD, PhD Sub-Investigator: Iván Alvarez-Twose, MD Collapse << |
NCT02157181 | Hairy Cell Leukemia (HCL) | Phase 2 | Completed | - | Germany ... more >> Community based hemato-oncology medical office Ansbach, Germany, 91522 Community based hemato-oncology medical office Aschaffenburg, Germany, 63739 Community based hemato-oncology medical office Celle, Germany, 29221 St.-Johannes-Hospital Dortmund, Germany, 44137 Städtische Kliniken Esslingen Esslingen, Germany, 73728 Universitätsklinik Frankfurt Frankfurt am Main, Germany, 60596 Universitätsklinik Freiburg Freiburg, Germany, 79106 Community based hemato-oncology medical office Fürth, Germany, 90766 University Clinic | Med. Cinic IV Justus-Liebig-University Gießen, Germany, 3592 Wilhelm-Anton-Hospital Goch, Germany, 47574 Kath. Krankenhaus Hagen gem. GmbH Hagen, Germany, 58095 Community based hemato-oncology medical office Halle, Germany, 06108 Community based hemato-oncology medical office Hamburg, Germany, 21073 Meditinische Hochschule (MHH) Hannover, Germany, 30623 Community based hemato-oncology medical office Heidelberg, Germany, 69115 Marienhospital Herne/ Klinikum der Ruhr-Universität Bochum Herne, Germany, 44625 Community based hemato-oncology medical office Hilden, Germany, 40721 Community based hemato-oncology medical office Hildesheim, Germany, 31134 Klinikum Idar-Oberstein Idar-Oberstein, Germany, 55743 Community based hemato-oncology medical office Jena, Germany, 07743 Community based hemato-oncology medical office Kassel, Germany, 34125 Community based hemato-oncology medical office Kiel, Germany, 24105 Community based hemato-oncology medical office Koblenz, Germany, 56068 Community based hemato-oncology medical office Kronach, Germany, 96317 Community based hemato-oncology medical office Leer, Germany, 26789 Community based hemato-oncology medical office Leipzig, Germany, 04103 Städtische Kliniken Leverkusen, Germany, 51375 Community based hemato-oncology medical office Magdeburg, Germany, 39104 Community based hemato-oncology medical office Marburg, Germany, 35037 Klinik Schwäbisch Gmünd / Staufer Klinik Mutlangen, Germany, 73557 Community based hemato-oncology medical office München, Germany, 80335 Community based hemato-oncology medical office München, Germany, 81241 Klinikum Großhadern München, Germany, 81377 Community based hemato-oncology medical office Neunkirchen, Germany, 66538 Community based hemato-oncology medical office Neuwied, Germany, 56564 Community based hemato-oncology medical office Niddatal, Germany, 61194 Community based hemato-oncology medical office Nürnberg, Germany, 90449 MVZ Klinikum Osnabrück Osnabrück, Germany, 49076 Community based hemato-oncology medical office Pforzheim, Germany, 75179 Klinikum Ernst von Bergmann gGmbH Potsdam, Germany, 14467 St. Josefs-Krankenhaus Potsdam, Germany, 14471 Community based hemato-oncology medical office Schweinfurt, Germany, 97421 St. Marien-Krankenhaus Siegen, Germany, 57072 Community based hemato-oncology medical office Straubing, Germany, 94315 Diakonie-Klinikum Stuttgart Stuttgart, Germany, 70176 Community based hemato-oncology medical office Villingen, Germany, 78050 Community based hemato-oncology medical office Wolfsburg, Germany, 38440 Collapse << |
NCT03491579 | AML Relapse | Phase 1 | Withdrawn(IMP will not be furt... more >>her developed) Collapse << | October 2019 | Switzerland ... more >> Departement of Medical Oncology, University Hospital Berne Berne, Switzerland, 3010 Collapse << |
NCT03181815 | Acute Myeloid Leukemia ... more >> Relapse Leukemia Collapse << | Phase 2 | Recruiting | May 1, 2019 | China, Guangdong ... more >> Liang Wang Recruiting Guangzhou, Guangdong, China, 510060 Contact: Liang Wang, M.D. +862087342439 wangliang@sysucc.org.cn Collapse << |
NCT03318419 | Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | December 31, 2020 | China, Guangdong ... more >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD. 0086-02087342438 dr_luyue@sina.com Collapse << |
NCT01013350 | - | - | Active, not recruiting | October 26, 2018 | United States, Massachusetts ... more >> Outcome Sciences, Inc Cambridge, Massachusetts, United States, 02139 Collapse << |
NCT02131753 | Hairy Cell Leukemia | Phase 2 Phase 3 | Recruiting | December 2027 | - |
NCT00938366 | Multiple Sclerosis | Phase 1 | Completed | - | - |
NCT00938366 | - | - | Completed | - | - |
NCT03745144 | Relapsing Multiple Sclerosis (... more >>RMS) Collapse << | Phase 1 | Not yet recruiting | January 15, 2020 | Germany ... more >> Please Contact the Merck KGaA Communication Center Not yet recruiting Darmstadt, Germany, 64293 Collapse << |
NCT03235973 | Leukemia, Myeloid, Acute ... more >> Leukemia, Lymphoblastic, Acute Collapse << | Phase 1 | Recruiting | April 2021 | France ... more >> Institut Paoli-Calmettes Recruiting Marseille, Bouches-du-Rhône, France, 13009 Contact: Dominique Genre, MD +33491223778 drci.up@ipc.unicancer.fr Principal Investigator: Raynier Devillier, MD,PhD Collapse << |
靶点 | Description | IC50 |
---|---|---|
Adenosine Deaminase | IC50:0.18μM(in MM1.S cells) |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网